Secretion of TGF-β and hypoxia-inducible factor-1α by tumors decreases the NKG2D activating receptor on NK cells and NKG2D ligand on tumor cells, respectively, tipping the scale in favor of NK cell inhibition (161). Here, KLRK1 is linked to neoplasm.